Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95263215 | 9526321 | 5 | F | 20130801 | 20160824 | 20130916 | 20160824 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-19184019 | BRISTOL MYERS SQUIBB | 27.46 | YR | F | Y | 70.00000 | KG | 20160824 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95263215 | 9526321 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | UNK | U | 21436 | TABLET | ||||||||
| 95263215 | 9526321 | 2 | C | CALONAL | ACETAMINOPHEN | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95263215 | 9526321 | 1 | Product used for unknown indication |
| 95263215 | 9526321 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95263215 | 9526321 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95263215 | 9526321 | Caesarean section | |
| 95263215 | 9526321 | Maternal exposure during pregnancy | |
| 95263215 | 9526321 | Normal newborn | |
| 95263215 | 9526321 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 95263215 | 9526321 | 2 | 20130728 | 0 |